[What can be learned from the new HAS AFM-Téléthon recommendations for clinical practice in musculoskeletal rehabilitation in neuromuscular pathologies?].

Over the past twenty years, the arrival of biotherapies and medical advances have changed the natural history of neuromuscular diseases and improved the life expectancy and quality of life of patients. It appeared necessary to propose new strategies in the rehabilitation of the musculoskeletal system. AFM-Telethon's medical actions department has initiated and organized, under the aegis of the Haute autorité de santé (HAS), a working group of experts, to write and validate new recommendations when implementing biotherapies, spinal instrumentation or exercise retraining. The expected impact of this update, validated at the beginning of 2024, is to offer more effective rehabilitation of the musculoskeletal system adapted to neuromuscular patients, allowing less recourse to hospitalization, harmonization of practices, wider dissemination of the new capacities offered to patients, an improvement of the quality and duration of life of patients, a reduction of inadequate procedures, an optimization of medical prescriptions integrating new data (therapy with neuromuscular disease).(exercise, better rehabilitation strategies, new equipment, new technical aids).